Icon

BREKIYA (AUTOINJECTOR) (NDA215400)- (1MG/ML)

DIHYDROERGOTAMINE MESYLATE AMNEAL
1MG/ML
No Yes
2039-Feb-26 Expired
None None
None No
BREKIYA is an ergotamine derivative indicated for the acute treatment of migraine with or without aura and the acute treatment of cluster headaches in adults.
0 0 0
Total Other Developers None
Drugs with Suitability No
1MG/ML ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.